A tiny RNA molecule shapes immune cells in plaques
Atherosclerosis turns dangerous when immune cells stop doing their job. A small piece of genetic material may decide which way those cells go.
When fatty deposits build up in artery walls, the body sends in macrophages — immune cells tasked with clearing the damage. But in advanced plaques, these cells get overwhelmed. They become inflammatory and eventually die, making the plaque larger and more dangerous.
Researchers have now identified microRNA-147 as a key player in this process. MicroRNAs are short RNA molecules that fine-tune protein production inside cells. They bind to messenger RNA and suppress the output of specific proteins. The researchers describe how microRNA-147 influences whether macrophages shift toward a healing role or an inflammatory one inside the plaque environment.
Two fates, one molecule
Not all macrophages are the same. Some reduce inflammation and help resolve the plaque. Others drive inflammation and fuel its growth. MicroRNA-147 appears to influence which path a macrophage takes, making it a potentially important target for new therapies.
Current treatments for atherosclerosis focus mainly on lowering cholesterol or thinning the blood. A microRNA-based approach would do something different: directly modulate the immune response inside the artery wall.
Why this matters for aging
Atherosclerosis is one of the leading causes of heart attacks and strokes, and risk rises sharply with age. As the immune system ages, macrophages become less effective at clearing plaques. Understanding the molecular steps behind that failure could open new paths to therapies that slow vascular aging.
Whether microRNA-147 behaves the same way in human tissue still needs to be confirmed. But the finding points to a new direction in understanding why atherosclerosis becomes so dangerous over time.